EastGate Pharmaceuticals Inc

Innovative Liquid Insulin Mouth Rinse for Type 2 Diabetes development

Facebook Twitter LinkedIn

We have developed an innovative liquid insulin mouth rinse for Type 2 diabetes patients. It is a game changer for the diabetes treatment space.   We are looking to initially explore the S. E. Asian market for this product and work with local partners who can navigate the regulatory scope of these markets and have the marketing savvy to capture even a small amount of the diabetes market.  

Ready to Ask For Funding for your company?

Post a Funding Request

EastGate Pharmaceuticals Inc is no longer seeking funding.